biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by rustycaton Sep 19, 2017 12:11am

205 Views

Post# 26712223

I think you guys need to take a breath and think about it

Whilst I don't see anything major happening quickly re commercial drug to market (but with the recent changes in the FDA's outlook, it certainly is possible it could be much faster than before), I have to say things are being set up with very distinct goals in mind, and everything looks to be ramping up to achieve those goals in a most expeditious manner. Take a breath and think positive thoughts.

Bullboard Posts

Dynamic Funds Launches new ETF series on the TSX